New Study Finds that Aspirin Could Help Lower Dementia Risk — and More Health Headlines
6 Articles
6 Articles
A recent study has shown that low doses of aspirin have been associated with a low risk of dementia among older persons who have
Aspirin's Cognitive Protection Is Genetically Determined by Platelet Levels
Scientists at Monash University, led by Peter Franske, have uncovered a genetic link that may determine aspirin's effectiveness in preventing cognitive decline. Their analysis of data from 13,500 participants in the ASPREE trial suggests that the protective benefits of aspirin against cognitive impairment are not universal but depend on an individual's genetic makeup. Genetic Key to Aspirin's Cognitive Benefits The research pinpointed specific g…
Australian researchers have revealed the possible benefit of aspirin in reducing the risk of dementia in a genetic analysis.
A Monash University study found that low doses of aspirin can reduce the risk of dementia by 70% in people with a certain genetic platelet profile.
A daily low dose of aspirin was associated with approximately 70 percent less dementia in elderly people with a genetic predisposition for high platelet counts. This emerged from a genetic review of a large aspirin study by researchers at Monash University in Australia. However, the benefit did have a downside. The case of aspirin and dementia seemed closed for a long time. […] More science? Read the latest articles on Scientias.nl.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
